Why Purple Biotech’s Flat Stock Signals Stagnation and Risk for Investors
Investors see Purple Biotech flat at ILA 1.00—no growth, no earnings, and limited liquidity. A cautious look at why this biotech lags behind peers.
3 minutes to read
PURPLE BIOTECH LTD